HealthQuill Smallpox
Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.
Drugs Health Pharma

Emergent gets US drug regulator’s nod to use its smallpox vaccine for mpox

Emergent BioSolutions Inc., got the US drug regulator’s approval to expand its smallpox vaccine use to treat mpox, according to a company statement.

Read More
Emergent BioSolutions, will sack 400 employees across its various facilities to focus on core business products meant to treat opioid overuse, anthrax, Ebola and smallpox.
Drugs Health Pharma

Emergent BioSolutions to cut 400 jobs to focus on core products

HQ Team August 9, 2023: Emergent BioSolutions, will sack 400 employees across its various facilities to focus on core business products meant to.

Read More
Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for the development of a monoclonal antibody-based product prototype to target orthopoxviruses.
Drugs Health Pharma

Germany’s Evotec wins $74 million US contract to make drug to fight orthopoxviruses

HQ Team July 5, 2023: Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for.

Read More
X